SCHEMBL5181701

SCHEMBL5181701

Cc1nc(OCc2ccc3c(c2)CCNCC3)ccc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 1/20 0.46
▸ MLNR O43193 4/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ PARP1 P09874 6/20 0.38
▸ RXRB P28702 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ SYK P43405 2/20 0.36
▸ AURKB Q96GD4 2/20 0.36
▸ INCENP Q9NQS7 2/20 0.36
▸ PLAU P00749 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5168811 0.84 MLNR (0.40) MLNRCYP2D6RXRBSYKAURKB
SCHEMBL3097058 0.81 NNMT (0.49) NNMTMLNRCYP2D6PARP1
SCHEMBL27538900 0.75 NNMT (0.56) NNMTPARP1NPC1CASP3RAB9A
SCHEMBL5663502 0.72 HRH3 (0.46) MLNRCYP2D6PARP1RXRBNPC1
SCHEMBL5660251 0.72 SYK (0.48) MLNRCYP2D6RXRBSYKAURKB
SCHEMBL4400842 0.70 NNMT (0.49) NNMT
SCHEMBL5168814 0.70 HRH3 (0.47) MLNRCYP2D6PARP1RXRBNPC1
SCHEMBL3077260 0.68 JAK2 (0.44) MLNRCYP2D6
SCHEMBL29421563 0.65 NNMT (1.00) NNMTNPC1RAB9A
SCHEMBL6309037 0.65 NNMT (1.00) NNMTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778643-A1 TETRAHYDROBENZAZEPINES AS ANTAGONISTS AND/OR REVERSE AGONISTS OF THE HISTAMINE H3 RECEPTOR GLAXO GROUP LIMITED (GB) 2007-05-02 — — EP disclosed
WO-2006018260-A1 TETRAHYDROBENZAZEPINES AS ANTAGONISTS AND/OR REVERSE AGONISTS OF THE HISTAMINE H 3 RECEPTOR GLAXO GROUP LIMITED (GB) 2006-02-23 — — WO disclosed
Send feedback